Serum C-reactive protein concentrations in dogs with multicentric lymphoma undergoing chemotherapy
Male
Lymphoma
Remission Induction
04 agricultural and veterinary sciences
3. Good health
Cohort Studies
0403 veterinary science
C-Reactive Protein
Dogs
Treatment Outcome
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Animals
Female
Neoplasm Recurrence, Local
DOI:
10.2460/javma.230.4.522
Publication Date:
2007-02-15T12:57:48Z
AUTHORS (5)
ABSTRACT
Abstract Objective —To determine whether serum C-reactive protein (CRP) concentration is high in dogs with multicentric lymphoma, CRP changes response to chemotherapy, and can be used as a marker for relapse lymphoma. Design —Cohort study. Animals —20 lymphoma 8 healthy control undergoing chemotherapy cyclophosphamide, vincristine, prednisone (CVP) or methotrexate, L-asparaginase (VCMA) 20 other dogs. Procedures —Serum was measured weekly during the first month of then at 3-week intervals until 16 weeks once not chemotherapy. Results —For both groups mean week 1 (prior treatment) significantly higher than concentrations following induction time relapse.Mean different any from chemotherapy.No significant dif ferences were observed between treated CVP VCMA. Conclusions Clinical Relevance —Results suggest that but useful itself does affect concentration.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (34)
CITATIONS (34)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....